Victory Capital Management
ETTX

Victory Capital Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Victory Capital Management’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-598
Closed -$2K – 3559
2020
Q1 		$2K Buy
+598
New +$2.69K ﹤0.01% 3708
2019
Q4 		– Sell
-286
Closed -$2K – 3543
2019
Q3 		$2K Buy
+286
New +$1.92K ﹤0.01% 3669

Other funds holding ETTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Victory Capital Management's ETTX Position: Q2 2020 in Review

Victory Capital Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q2 2020, closing a stake of 598 shares — an estimated $2K sold.

Victory Capital Management first reported a position in ETTX in Q3 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 22 funds tracked by Wall St. Rank hold ETTX as of Q2 2020.

  • Victory Capital Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 598 Entasis Therapeutics Holdings Inc. shares in Q2 2020, an estimated $2K.
  • Victory Capital Management first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Entasis Therapeutics Holdings Inc. position peaked at $2K in Q1 2020.
  • 22 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.